Depression: Difference between revisions
No edit summary |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
**Appetite disturbance or weight loss | **Appetite disturbance or weight loss | ||
**Psychomotor retardation/agitation | **Psychomotor retardation/agitation | ||
**Suicidal thoughts | **[[suicide|Suicidal thoughts]] | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 19: | Line 19: | ||
==Evaluation== | ==Evaluation== | ||
Depression screening with PHQ-9, the PHQ-2, the Beck Depression Inventory for Primary Care, and the WHO-5 | *Evaluate [[suicide risk]] | ||
*Depression screening with PHQ-9, the PHQ-2, the Beck Depression Inventory for Primary Care, and the WHO-5 | |||
{{General ED Psychiatric Workup}} | {{General ED Psychiatric Workup}} | ||
==Management== | ==Management== | ||
* | *Psych consult or admission if high risk of [[suicide]] | ||
* | *Consider consult with psychiatric team in other cases, particularly if severe symptoms and patient not already plugged into psych care | ||
*Pharmacologic agents (typically not started in ED due to need for monitoring and adjustment) | |||
**SSRIs (citalopram, fluoxetine, paroxetine, sertraline) | **SSRIs (citalopram, fluoxetine, paroxetine, sertraline) | ||
**SNRIs ([[duloxetine]], [[venlafaxine]], milnacipran) | **SNRIs ([[duloxetine]], [[venlafaxine]], milnacipran) | ||
Revision as of 17:00, 10 October 2019
Background
Clinical Features
Major Depressive Disorder (MDD) - Must have 5 of the following features for >2 wks[1]
- Depressed mood or anhedonia (must be present)
- SIGECAPS
- Sleep decreased (Insomnia with 2-4 am awakening)
- Interest decreased in activities
- Guilt or worthlessness (Not a major criteria)
- Energy decreased
- Concentration difficulties
- Appetite disturbance or weight loss
- Psychomotor retardation/agitation
- Suicidal thoughts
Differential Diagnosis
General Psychiatric
- Organic causes
- Psychiatric causes
Evaluation
- Evaluate suicide risk
- Depression screening with PHQ-9, the PHQ-2, the Beck Depression Inventory for Primary Care, and the WHO-5
General ED Psychiatric Workup
- Point-of-care glucose
- CBC
- Chem 7
- LFTs
- ECG (for toxicology evaluation)
- ASA level
- Tylenol level
- Urine toxicology screen/Blood toxicology screen
- EtOH
- Urine pregnancy/beta-hCG (if female of childbearing age)
- Consider:
- Ammonia (see Hepatic encephalopathy)
- TSH (hypo or hyperthyroidism may mimic mental illness)
- CXR (for Tb screen or rule-out delirium in older patient)
- UA (for rule-out delirium in older patients)
- Head CT (to rule-out ICH in patients with AMS)
- Lumbar puncture (to rule-out meningitis or encephalitis)
Management
- Psych consult or admission if high risk of suicide
- Consider consult with psychiatric team in other cases, particularly if severe symptoms and patient not already plugged into psych care
- Pharmacologic agents (typically not started in ED due to need for monitoring and adjustment)
- SSRIs (citalopram, fluoxetine, paroxetine, sertraline)
- SNRIs (duloxetine, venlafaxine, milnacipran)
- Serotonin modulators (trazodone)
- Atypical (bupropion, mirtazapine)
- TCAs (amitriptyline, clomipramine, desipramine, doxepin, imipramine, nortriptyline, trimipramine)
- MAOIs (isocarboxazid, phenelzine, selegiline)
Disposition
See Also
External Links
References
- ↑ American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.